Cell Growth & Differentiation, Vol 9, Issue 5 393-404, Copyright © 1998 by American Association of Cancer Research

ARTICLES

Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion

G Portella, SA Cumming, J Liddell, W Cui, H Ireland, RJ Akhurst and A Balmain
Department of Medical Oncology, Glasgow University, United Kingdom.

Transforming growth factor beta1 (TGF-beta1) regulates both cell growth and cellular plasticity and is therefore important in the molecular control of both the developmental and neoplastic processes. It has been suggested that TGF-beta1 may be a positive or negative regulator of tumorigenesis. Stimulation of tumorigenesis could be due to its action as an immunosuppressor or as an inducer of angiogenesis, or by its direct action on the cell in promoting cellular plasticity. In the current study, we provide evidence that TGF-beta1 can act directly on keratinocytes in vivo to induce the reversible epithelial-mesenchymal conversion of a malignant metastatic keratinocyte cell line. Two squamous clones from the cell line were shown to undergo a reversible conversion to a fibroblastoid phenotype after culture in 1 ng/ml TGF-beta1. The morphological conversion became apparent at 24 h post-TGF-beta treatment and was complete after another 24 h. The conversion was characterized by a rapid delocalization of E-cadherin within 6-12 h posttreatment, followed by down-regulation of E-cadherin levels by 72 h. These squamous clones spontaneously converted to a fibroblastoid phenotype after s.c. injection in nude mice. Importantly, four of four clones that had been stably transfected with a dominant negative TGF-beta type II receptor were unable to undergo this mesenchymal switch in vivo, despite the fact that all clones stably transfected with neomyocin resistance alone retained their spindle characteristics in vivo. This demonstrates that the epithelial-mesenchymal conversion event is mediated directly via the TGF-beta signaling pathway of the tumor cell per se, and that it is sufficient to significantly enhance tumorigenicity and the malignant and invasive characteristics of the tumor in vivo.

This article has been cited by other articles:

				D. Romero, M. Iglesias, C. P.H. Vary, and M. Quintanilla Functional blockade of Smad4 leads to a decrease in {beta}-catenin levels and signaling activity in human pancreatic carcinoma cells Carcinogenesis, May 1, 2008; 29(5): 1070 - 1076. [Abstract] [Full Text] [PDF]

				E. Perez-Gomez, M. Villa-Morales, J. Santos, J. Fernandez-Piqueras, C. Gamallo, J. Dotor, C. Bernabeu, and M. Quintanilla A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis Cancer Res., November 1, 2007; 67(21): 10268 - 10277. [Abstract] [Full Text] [PDF]

				K. L. Andarawewa, A. C. Erickson, W. S. Chou, S. V. Costes, P. Gascard, J. D. Mott, M. J. Bissell, and M. H. Barcellos-Hoff Ionizing Radiation Predisposes Nonmalignant Human Mammary Epithelial Cells to Undergo Transforming Growth Factor {beta} Induced Epithelial to Mesenchymal Transition Cancer Res., September 15, 2007; 67(18): 8662 - 8670. [Abstract] [Full Text] [PDF]

				T. Shirakihara, M. Saitoh, and K. Miyazono Differential Regulation of Epithelial and Mesenchymal Markers by {delta}EF1 Proteins in Epithelial Mesenchymal Transition Induced by TGF-beta Mol. Biol. Cell, September 1, 2007; 18(9): 3533 - 3544. [Abstract] [Full Text] [PDF]

				J. Beisner, M. B. Buck, P. Fritz, J. Dippon, M. Schwab, H. Brauch, G. Zugmaier, K. Pfizenmaier, and C. Knabbe A Novel Functional Polymorphism in the Transforming Growth Factor-{beta}2 Gene Promoter and Tumor Progression in Breast Cancer. Cancer Res., August 1, 2006; 66(15): 7554 - 7561. [Abstract] [Full Text] [PDF]

				H. Azuma, S. Ehata, H. Miyazaki, T. Watabe, O. Maruyama, T. Imamura, T. Sakamoto, S. Kiyama, Y. Kiyama, T. Ubai, et al. Effect of Smad7 Expression on Metastasis of Mouse Mammary Carcinoma JygMC(A) Cells J Natl Cancer Inst, December 7, 2005; 97(23): 1734 - 1746. [Abstract] [Full Text] [PDF]

				U. Valcourt, M. Kowanetz, H. Niimi, C.-H. Heldin, and A. Moustakas TGF-{beta} and the Smad Signaling Pathway Support Transcriptomic Reprogramming during Epithelial-Mesenchymal Cell Transition Mol. Biol. Cell, April 1, 2005; 16(4): 1987 - 2002. [Abstract] [Full Text] [PDF]

				S.S. Prime, M. Davies, M. Pring, and I.C. Paterson THE ROLE OF TGF-{beta} IN EPITHELIAL MALIGNANCY AND ITS RELEVANCE TO THE PATHOGENESIS OF ORAL CANCER (PART II) Crit. Rev. Oral. Biol. Med., November 1, 2004; 15(6): 337 - 347. [Abstract] [Full Text] [PDF]

				H. G. Munshi, Y. I. Wu, S. Mukhopadhyay, A. J. Ottaviano, A. Sassano, J. E. Koblinski, L. C. Platanias, and M. S. Stack Differential Regulation of Membrane Type 1-Matrix Metalloproteinase Activity by ERK 1/2- and p38 MAPK-modulated Tissue Inhibitor of Metalloproteinases 2 Expression Controls Transforming Growth Factor-{beta}1-induced Pericellular Collagenolysis J. Biol. Chem., September 10, 2004; 279(37): 39042 - 39050. [Abstract] [Full Text] [PDF]

				P.-L. So, K. Lee, J. Hebert, P. Walker, Y. Lu, J. Hwang, L. Kopelovich, M. Athar, D. Bickers, M. Aszterbaum, et al. Topical Tazarotene Chemoprevention Reduces Basal Cell Carcinoma Number and Size in Ptch1+/- Mice Exposed to Ultraviolet or Ionizing Radiation Cancer Res., July 1, 2004; 64(13): 4385 - 4389. [Abstract] [Full Text] [PDF]

				R. L. de Cicco, J. C. Watson, D. E. Bassi, S. Litwin, and A. J. Klein-Szanto Simultaneous Expression of Furin and Vascular Endothelial Growth Factor in Human Oral Tongue Squamous Cell Carcinoma Progression Clin. Cancer Res., July 1, 2004; 10(13): 4480 - 4488. [Abstract] [Full Text] [PDF]

				S. E. Seton-Rogers, Y. Lu, L. M. Hines, M. Koundinya, J. LaBaer, S. K. Muthuswamy, and J. S. Brugge Cooperation of the ErbB2 receptor and transforming growth factor {beta} in induction of migration and invasion in mammary epithelial cells PNAS, February 3, 2004; 101(5): 1257 - 1262. [Abstract] [Full Text] [PDF]

				W. Li, W. Qiao, L. Chen, X. Xu, X. Yang, D. Li, C. Li, S. G. Brodie, M. M. Meguid, L. Hennighausen, et al. Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice Development, December 15, 2003; 130(24): 6143 - 6153. [Abstract] [Full Text] [PDF]

				R. S. Muraoka, Y. Koh, L. R. Roebuck, M. E. Sanders, D. Brantley-Sieders, A. E. Gorska, H. L. Moses, and C. L. Arteaga Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor {beta}1 Mol. Cell. Biol., December 1, 2003; 23(23): 8691 - 8703. [Abstract] [Full Text] [PDF]

				C. C. Park, R. L. Henshall-Powell, A. C. Erickson, R. Talhouk, B. Parvin, M. J. Bissell, and M. H. Barcellos-Hoff Ionizing radiation induces heritable disruption of epithelial cell interactions PNAS, September 16, 2003; 100(19): 10728 - 10733. [Abstract] [Full Text] [PDF]

				P. M. Siegel, W. Shu, R. D. Cardiff, W. J. Muller, and J. Massague Transforming growth factor {beta} signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis PNAS, July 8, 2003; 100(14): 8430 - 8435. [Abstract] [Full Text] [PDF]

				H. Peinado, M. Quintanilla, and A. Cano Transforming Growth Factor {beta}-1 Induces Snail Transcription Factor in Epithelial Cell Lines: MECHANISMS FOR EPITHELIAL MESENCHYMAL TRANSITIONS J. Biol. Chem., May 30, 2003; 278(23): 21113 - 21123. [Abstract] [Full Text] [PDF]

				R. C. Bates and A. M. Mercurio Tumor Necrosis Factor-{alpha} Stimulates the Epithelial-to-Mesenchymal Transition of Human Colonic Organoids Mol. Biol. Cell, May 1, 2003; 14(5): 1790 - 1800. [Abstract] [Full Text] [PDF]

				N. Dumont, A. V. Bakin, and C. L. Arteaga Autocrine Transforming Growth Factor-beta Signaling Mediates Smad-independent Motility in Human Cancer Cells J. Biol. Chem., January 24, 2003; 278(5): 3275 - 3285. [Abstract] [Full Text] [PDF]

				E. P. Bottinger and M. Bitzer TGF-{beta} Signaling in Renal Disease J. Am. Soc. Nephrol., October 1, 2002; 13(10): 2600 - 2610. [Abstract] [Full Text] [PDF]

				E. Psichari, A. Balmain, D. Plows, V. Zoumpourlis, and A. Pintzas High Activity of Serum Response Factor in the Mesenchymal Transition of Epithelial Tumor Cells Is Regulated by RhoA Signaling J. Biol. Chem., August 9, 2002; 277(33): 29490 - 29495. [Abstract] [Full Text] [PDF]

				K. B. Ewan, G. Shyamala, S. A. Ravani, Y. Tang, R. Akhurst, L. Wakefield, and M. H. Barcellos-Hoff Latent Transforming Growth Factor-{beta} Activation in Mammary Gland : Regulation by Ovarian Hormones Affects Ductal and Alveolar Proliferation Am. J. Pathol., June 1, 2002; 160(6): 2081 - 2093. [Abstract] [Full Text] [PDF]

				L. Van Aelst and M. Symons Role of Rho family GTPases in epithelial morphogenesis Genes & Dev., May 1, 2002; 16(9): 1032 - 1054. [Full Text] [PDF]

				J. Gotzmann, H. Huber, C. Thallinger, M. Wolschek, B. Jansen, R. Schulte-Hermann, H. Beug, and W. Mikulits Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-{beta}1 and Ha-Ras: steps towards invasiveness J. Cell Sci., March 15, 2002; 115(6): 1189 - 1202. [Abstract] [Full Text] [PDF]

				A. V. Bakin, C. Rinehart, A. K. Tomlinson, and C. L. Arteaga p38 mitogen-activated protein kinase is required for TGF{beta}-mediated fibroblastic transdifferentiation and cell migration J. Cell Sci., January 8, 2002; 115(15): 3193 - 3206. [Abstract] [Full Text] [PDF]

				M. A. Rowland-Goldsmith, H. Maruyama, K. Matsuda, T. Idezawa, M. Ralli, S. Ralli, and M. Korc Soluble Type II Transforming Growth Factor-{beta} Receptor Attenuates Expression of Metastasis-associated Genes and Suppresses Pancreatic Cancer Cell Metastasis Mol. Cancer Ther., January 1, 2002; 1(3): 161 - 167. [Abstract] [Full Text] [PDF]

				I. Shin, A. V. Bakin, U. Rodeck, A. Brunet, and C. L. Arteaga Transforming Growth Factor beta Enhances Epithelial Cell Survival via Akt-dependent Regulation of FKHRL1 Mol. Biol. Cell, November 1, 2001; 12(11): 3328 - 3339. [Abstract] [Full Text] [PDF]

				P. J. Stahl and D. Felsen Transforming Growth Factor-{beta}, Basement Membrane, and Epithelial-Mesenchymal Transdifferentiation : Implications for Fibrosis in Kidney Disease Am. J. Pathol., October 1, 2001; 159(4): 1187 - 1192. [Full Text]

				M. A. Rowland-Goldsmith, H. Maruyama, T. Kusama, S. Ralli, and M. Korc Soluble Type II Transforming Growth Factor-{beta} (TGF-{beta}) Receptor Inhibits TGF-{beta} Signaling in COLO-357 Pancreatic Cancer Cells in Vitro and Attenuates Tumor Formation Clin. Cancer Res., September 1, 2001; 7(9): 2931 - 2940. [Abstract] [Full Text] [PDF]

				D. L. Hulboy, L. M. Matrisian, and H. C. Crawford Loss of JunB Activity Enhances Stromelysin 1 Expression in a Model of the Epithelial-to-Mesenchymal Transition of Mouse Skin Tumors Mol. Cell. Biol., August 15, 2001; 21(16): 5478 - 5487. [Abstract] [Full Text] [PDF]

				J. Zavadil, M. Bitzer, D. Liang, Y.-C. Yang, A. Massimi, S. Kneitz, E. Piek, and E. P. Bottinger Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta PNAS, June 5, 2001; 98(12): 6686 - 6691. [Abstract] [Full Text] [PDF]

				V. Ellenrieder, S. F. Hendler, W. Boeck, T. Seufferlein, A. Menke, C. Ruhland, G. Adler, and T. M. Gress Transforming Growth Factor {beta}1 Treatment Leads to an Epithelial-Mesenchymal Transdifferentiation of Pancreatic Cancer Cells Requiring Extracellular Signal-regulated Kinase 2 Activation Cancer Res., May 1, 2001; 61(10): 4222 - 4228. [Abstract] [Full Text]

				N. A. Bhowmick, M. Ghiassi, A. Bakin, M. Aakre, C. A. Lundquist, M. E. Engel, C. L. Arteaga, and H. L. Moses Transforming Growth Factor-{beta}1 Mediates Epithelial to Mesenchymal Transdifferentiation through a RhoA-dependent Mechanism Mol. Biol. Cell, January 1, 2001; 12(1): 27 - 36. [Abstract] [Full Text]

				N. H. Machell, O. W. Blaschuk, and R. Farookhi Developmental Expression and Distribution of N- and E-Cadherin in the Rat Ovary Biol Reprod, September 1, 2000; 63(3): 797 - 804. [Abstract] [Full Text]

				I. Ganly, V. Mautner, and A. Balmain Productive Replication of Human Adenoviruses in Mouse Epidermal Cells J. Virol., March 15, 2000; 74(6): 2895 - 2899. [Abstract] [Full Text]

				B. Tang, K. de Castro, H. E. Barnes, W. T. Parks, L. Stewart, E. P. Bottinger, D. Danielpour, and L. M. Wakefield Loss of Responsiveness to Transforming Growth Factor {beta} Induces Malignant Transformation of Nontumorigenic Rat Prostate Epithelial Cells Cancer Res., October 1, 1999; 59(19): 4834 - 4842. [Abstract] [Full Text] [PDF]

				R. Montesano, J. V. Soriano, G. Hosseini, M. S. Pepper, and H. Schramek Constitutively Active Mitogen-activated Protein Kinase Kinase MEK1 Disrupts Morphogenesis and Induces an Invasive Phenotype in Madin-Darby Canine Kidney Epithelial Cells Cell Growth Differ., May 1, 1999; 10(5): 317 - 332. [Abstract] [Full Text]

				E Piek, A Moustakas, A Kurisaki, C. Heldin, and P ten Dijke TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells J. Cell Sci., January 12, 1999; 112(24): 4557 - 4568. [Abstract] [PDF]